Independent Portfolio Consultants’s Integra LifeSciences IART Stock Holding History

Independent Portfolio Consultants’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$996K	Sell	18,265 -7,085	-28%	-$338K	0.41%	51
2017 Q1	$1.07M	Buy	25,350 +1,200	+5%	+$51.3K	0.37%	70
2016 Q4	$1.04M	Buy	24,150 +630	+3%	+$25.6K	0.34%	83
2016 Q3	$971K	Buy	23,520 +20	+0.1%	+$838	0.3%	98
2016 Q2	$937K	Buy	23,500 +7,850	+50%	+$282K	0.3%	99
2016 Q1	$527K	Sell	15,650 -40	-0.3%	-$1.25K	0.15%	203
2015 Q4	$532K	Sell	15,690 -7,540	-32%	-$236K	0.16%	183
2015 Q3	$692K	Buy	23,230 +417	+2%	+$13K	0.15%	197
2015 Q2	$628K	Buy	22,813 +1,186	+5%	+$31.6K	0.13%	216
2015 Q1	$545K	Sell	21,627 -1,003	-4%	-$23.7K	0.11%	229
2014 Q4	$502K	Buy	+22,630	New	+$459K	0.1%	246

Other funds holding IART

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Independent Portfolio Consultants's IART Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Integra LifeSciences (IART) stake by 28% in Q2 2017, selling an estimated $338K and leaving 18,265 shares worth $996K. The position accounts for 0.41% of the portfolio, ranked #51.

Independent Portfolio Consultants first reported a position in IART in Q4 2014 and has held it in 11 quarters since. The position peaked at $1.07M in Q1 2017. 224 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Independent Portfolio Consultants held 18,265 shares of Integra LifeSciences worth $996K as of Q2 2017.
Independent Portfolio Consultants sold 7,085 Integra LifeSciences shares in Q2 2017, an estimated $338K.
Integra LifeSciences made up 0.41% of Independent Portfolio Consultants's portfolio in Q2 2017, its #51 holding.
Independent Portfolio Consultants first reported a position in Integra LifeSciences in Q4 2014 and has held it in 11 quarters since.
Independent Portfolio Consultants's Integra LifeSciences position peaked at $1.07M in Q1 2017.
224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.